Delivery Order SPE2DB22D9239-SPE2DB25FDM37
Award Date 9/28/25
Potential Completion Date 9/29/25
Potential Value $267K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for 120 units of Xtandi 40 mg capsules, with a contract ceiling value of $4,311.35. The award, finalized on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. This order will be fulfilled at DMS Pharmaceutical Group's location in Park Ridge,...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $33,923.76 for 120-count supplies of Xtandi 40 mg capsules. The award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, reflects a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its facility location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,480.94 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order was issued without set-aside designation and is being performed in Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the awardee under its...
- The U.S. Defense Logistics Agency (DLA), through the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xtandi 40 mg capsules (120 count units) valued at $4,311.35. This firm fixed-price delivery order, issued under no set-aside designation, is scheduled for completion by August 26, 2025, with fulfillment from the vendor's Park Ridge, Illinois location. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a $4.3K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). The contract, issued as a firm fixed-price delivery order on September 9, 2025, with completion scheduled for September 10, 2025, represents a single pharmaceutical product delivery supporting Department of Defense healthcare operations. This award carries no...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count packages). The contract, valued at $4,311.35, carries a firm fixed-price arrangement with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in open federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The contractor, a...